The latest closing stock price for Oncobiologics as of February 24, 2025 is 1.52.
An investor who bought $1,000 worth of Oncobiologics stock at the IPO in 2016 would have $-998 today, roughly -1 times their original investment - a -49.27% compound annual growth rate over 9 years.
The all-time high Oncobiologics stock closing price was 867.20 on September 06, 2016.
The Oncobiologics 52-week high stock price is 12.85, which is 745.4% above the current share price.
The Oncobiologics 52-week low stock price is 0.87, which is 42.8% below the current share price.
The average Oncobiologics stock price for the last 52 weeks is 5.98.
An investor who bought $1,000 worth of Oncobiologics stock at the IPO in 2016 would have $-998 today, roughly -1 times their original investment - a -49.27% compound annual growth rate over 9 years.
The all-time high Oncobiologics stock closing price was 867.20 on September 06, 2016.
The Oncobiologics 52-week high stock price is 12.85, which is 745.4% above the current share price.
The Oncobiologics 52-week low stock price is 0.87, which is 42.8% below the current share price.
The average Oncobiologics stock price for the last 52 weeks is 5.98.